Hideki Azuma
- Molecular Biology
- Psychiatry and Mental health top 5%
- Pharmacology top 5%
- Organic Chemistry top 10%
- Oncology
- Co-authors
- Kenji OginoToshi A. FurukawaTatsuo AkechiSeizo TamagakiTaro TachibanaTakeshi NagasakiJun‐ichi KidoToshihiko Nagata
- Topics
- Sphingolipid Metabolism and Signaling (8 papers)Electroconvulsive Therapy Studies (8 papers)Treatment of Major Depression (8 papers)
- Journals
- BloodBiomaterialsBiochemical Journal
- Partner nations
- JapanUnited StatesCanada
In The Last Decade
Hideki Azuma
61 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 122
- Molecular Biology 356
- Psychiatry and Mental health 224
- Pharmacology 181
- Organic Chemistry 170
- Oncology 89
Countries citing papers authored by Hideki Azuma
This map shows the geographic impact of Hideki Azuma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideki Azuma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideki Azuma more than expected).
Fields of papers citing papers by Hideki Azuma
This network shows the impact of papers produced by Hideki Azuma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideki Azuma. The network helps show where Hideki Azuma may publish in the future.
Co-authorship network of co-authors of Hideki Azuma
This figure shows the co-authorship network connecting the top 25 collaborators of Hideki Azuma. A scholar is included among the top collaborators of Hideki Azuma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideki Azuma. Hideki Azuma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 9 | |
| 5 | 9 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 29 | |
| 9 | 15 | |
| 10 | 12 | |
| 11 | 8 | |
| 12 | 10 | |
| 13 | 24 | |
| 14 | 11 | |
| 15 | 29 | |
| 16 | 22 | |
| 17 | 31 | |
| 18 | 28 | |
| 19 | 12 | |
| 20 | 10 |
About Hideki Azuma
Hideki Azuma is a scholar working on Psychiatry and Mental health, Pharmacology and Pharmacology, having authored 65 papers that have together received 1.1k indexed citations. Recurring topics across this work include Sphingolipid Metabolism and Signaling (8 papers), Electroconvulsive Therapy Studies (8 papers) and Treatment of Major Depression (8 papers). The work is most often cited by research in Psychiatry and Mental health (224 citations), Pharmacology (181 citations) and Toxicology (35 citations). Hideki Azuma has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Kenji Ogino, Toshi A. Furukawa, Tatsuo Akechi, Seizo Tamagaki, Taro Tachibana, Takeshi Nagasaki, Jun‐ichi Kido, Toshihiko Nagata, Akiko Kojima‐Yuasa and Isao Matsui‐Yuasa. Their work appears in journals such as Blood, Biomaterials and Biochemical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.